Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2013.12.27
第二届监事会第二十六次聚会决议通告
2013.12.27
第二届董事会第二十九次聚会决议通告
2013.12.27
关于重大资产重组的一样平常危害提醒暨复牌通告
2013.12.27
董事会关于重组推行法定程序完整性、合规性及提交的执法文件有用性的说明
2013.12.27
中国中投证券有限责任公司关于公司拟以部分超募资金对全资子公司举行增资暨收购美国公...
2013.12.27
生意对方允许与声明
2013.12.27
关于使用部分超募资金对全资子公司举行增资的通告
2013.12.27
重大资产购置预案
2013.12.24
关于重大资产重组事项的希望通告
2013.12.17
关于重大资产重组事项的希望通告
第一页
上一页
114
115
116
117
118
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】